4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-009179
Director sold 35,000 shares at an average $31.89 ($1,116,072)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MILNE GEORGE M JR Director | 2023-03-16 | Sale | −33,084 | $31.86 | $1,053,901 | 863,937 | D |
| MILNE GEORGE M JR Director | 2023-03-16 | Sale | −1,916 | $32.45 | $62,172 | 862,021 | D |
| Open-market sales · 35,000 sh · avg $31.89 · $1,116,072 | |||||||
Loading xslF345X04/doc4.xml…